EF-hand domains of MCFD2 mediate interactions with both LMAN1 and coagulation factor V or VIII

Chunlei Zheng1, Hui-hui Liu, Jiahai Zhou

  • 1Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic Foundation, OH 44195, USA.

Blood
|December 17, 2009
PubMed

Insights

Mutations in MCFD2 cause a bleeding disorder by disrupting the LMAN1-MCFD2 cargo receptor. The EF-hand domains of MCFD2 bind LMAN1 and factor V/VIII, crucial for protein transport.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Genetics

Background:

  • Combined deficiency of factor V and factor VIII (F5F8D) is a rare bleeding disorder.
  • Mutations in LMAN1 or MCFD2 genes cause F5F8D.
  • LMAN1 and MCFD2 form a calcium-dependent cargo receptor essential for FV/FVIII transport.

Purpose of the Study:

  • To investigate the structural and functional domains of MCFD2 involved in LMAN1 and FV/FVIII binding.
  • To elucidate the role of calcium-induced folding in MCFD2-LMAN1 interactions.
  • To understand the mechanism of cargo receptor formation and loading in the ER.

Main Methods:

  • Site-directed mutagenesis of MCFD2.
  • Analysis of LMAN1-binding and FV/FVIII-binding activities.
  • Circular dichroism spectroscopy to study protein folding and calcium-induced conformational changes.

Main Results:

  • The C-terminal EF-hand domains of MCFD2 are necessary and sufficient for LMAN1 interaction.
  • Calcium-induced folding of EF-hand domains is critical for LMAN1 binding.
  • MCFD2 binds FV/FVIII independently of calcium-induced folding, suggesting distinct binding sites.
  • Mutations disrupting LMAN1 binding do not affect FV/FVIII binding.

Conclusions:

  • MCFD2 EF-hand domains possess separate binding sites for LMAN1 and FV/FVIII.
  • These distinct sites are crucial for cargo receptor assembly and efficient FV/FVIII ER-to-Golgi transport.
  • Understanding these interactions may inform therapeutic strategies for F5F8D.

Related Concept Videos

Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Mechanisms of Membrane Domain Formation00:59

Mechanisms of Membrane Domain Formation

Different physical properties of lipids and proteins allow them to localize and form distinct islands or domains in the membrane. Some membrane domains are formed due to protein-protein interactions, whereas others are formed due to the presence of specific lipids such as sphingolipids and sterols—for example, large proteins, such as bacteriorhodopsin, aggregate and create distinct domains.
Another mechanism for membrane domain formation involves membrane proteins interacting with cytoskeletal...